Related Experiment Video

Updated: May 29, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

[Promising approaches of translational research in head and neck cancer]

A Dietz1

  • 1Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde, Universitätsklinikum Leipzig, Liebigstr. 10-14, 04103, Leipzig, Deutschland. andreas.dietz@medizin.uni-leipzig.de

HNO
|September 6, 2011
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Experiment Videos

Last Updated: May 29, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Articles linked to this work by shared authors, journal, and citation graph.

A simple clinical risk score can predict frailty in HNSCC patients.

Cancer treatment and research communications·2026

A multiomic framework for predicting laryngo-esophageal dysfunction following induction chemotherapy in hypopharyngeal-laryngeal carcinoma.

ESMO open·2025

Automatic electrode scalar location assessment after cochlear implantation using a novel imaging software.

Scientific reports·2023

Structure and establishment of the German Cochlear Implant Registry (DCIR).

HNO·2023

Conception and implementation of a certification system for quality control of cochlear implant treatment in Germany.

HNO·2023

[Structure and establishment of the German Cochlear Implant Registry].

HNO·2023

[Methodological implications of the minimal clinically important difference in patient-reported outcome measures in the field of cochlear implant provision. German version].

HNO·2026

[Preventive approaches in phoniatrics and musicians' medicine-voice physiology and vocal health curriculum content during the training of vocal students].

HNO·2026

Implantation of a transcutaneous, bone-anchored, piezoelectric bone conduction hearing aid on the squama temporalis.

HNO·2026

[Special tumor entities : New results at the 2026 ASCO Annual Meeting].

HNO·2026

[Support needs of people with intellectual disabilities after hearing aid provision].

HNO·2026

[Surgical trials in head and neck cancer at the 2026 ASCO Annual Meeting].

HNO·2026

Senomorphic miR-3155b suppresses the senescence-associated secretory phenotype in therapy-induced senescence.

Frontiers in cell and developmental biology·2026

Predictive biomarkers for precision treatment in rheumatoid arthritis: are we there yet?

Frontiers in pharmacology·2026

Breaking the ERK1/2 negative feedback loop: avoiding reactivation and acquisition of resistance by ERK1/2 to anti-cancer agents.

Frontiers in oncology·2026

Clinical trial landscape and translational priorities for adoptive T-cell and NK-cell therapies in gynecologic malignancies.

Frontiers in immunology·2026

Oncolytic reovirus: tumor-microenvironment remodeling, engineering constraints, and translational strategies.

Frontiers in immunology·2026

Profiling crystal engineered ligands for targeting treatment resistant androgen receptors.

Frontiers in pharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us